Medidata is named by Forbes as one of the world's most innovative
companies and listed as a Great Place to Work by FORTUNE. Medidata
is the only company in its space to appear on either list
NEW YORK--(BUSINESS WIRE)--
(NASDAQ: MDSO), the leading global provider of cloud-based technology
and data analytics for clinical research, today announced that it has
received recognition from two prestigious business publications for its
innovation and work environment. Medidata is the only technology company
within the global life sciences sector to receive either award.
Forbes magazine named Medidata as one of The
World's Most Innovative Growth Companies for 2017, and is ranked
59th globally. Additionally, the company has for the second consecutive
year been listed a Best
Workplace in New York by FORTUNE, ranking 16th among large companies
in New York.
"Our ability to attract and retain an incredibly skilled, diverse,
motivated and empowered workforce goes hand-in-hand with the impressive
innovation we're bringing to market," said Glen de Vries, Medidata
president and co-founder. "Investment in the growth and engagement of
our employees is a core value for Medidata, and we firmly believe that
the return on investment is enormous. Thanks to our strong team, we are
able to deliver to our customers innovative technology and solutions,
which address real research and business issues they face today, as well
as those of the future."
An example of such technology is Medidata's
Synthetic Control Arm (SCA), which reuses subject level data from
multiple historic clinical trials to create a well-matched,
patient-level comparator group without recruiting new control patients.
SCA provides better science and efficiency for clinical trials by
creating a data-based, low-bias, high-confidence comparator for
interpreting the uncontrolled treatment.
The Forbes's list of Most Innovative Growth Companies for 2017 is based
on investors' ability to identify firms they expect to be innovative now
and in the future. To qualify, firms need seven years of public
financial data between $2-10 billion in market cap and they need to
belong to an industry that is known to invest in innovation.
The Best Workplaces in New York is one of a series
of rankings by Great Place to Work and FORTUNE based on employee
feedback from Great Place to Work-Certified™ organizations. The list
considered 137,000 employee surveys about culture, leadership, benefits
and other factors crucial to an outstanding employee experience.
is reinventing global drug and medical device development by creating
the industry's leading cloud-based solutions for clinical research.
Through our advanced applications and intelligent data analytics,
Medidata helps advance the scientific goals of life sciences customers
worldwide, including more than 850 global pharmaceutical companies,
innovative biotech, diagnostic and device firms, leading academic
medical centers, and contract research organizations.
The Medidata Clinical Cloud® brings a new level of quality
and efficiency to clinical trials that empower our customers to make
more informed decisions earlier and faster. Our unparalleled clinical
trial data assets provide deep insights that pave the way for future
growth. The Medidata Clinical Cloud is the primary technology solution
powering clinical trials for 18 of the world's top 25 global
pharmaceutical companies and is used by 18 of the top 25 medical device
developers—from study design and planning through execution, management
View source version on businesswire.com: http://www.businesswire.com/news/home/20170807005306/en/
D'Amico, +1 732-767-4331
Snider, +1 646-362-2997
News Provided by Acquire Media